compound, pharmaceutical composition, compound use, method for elevating hdl in an individual, method for treating type 2 diabetes, decreased insulin resistance or lowering blood pressure in an individual, method for decreasing ldlc in an individual , method for displacing small dense ldl particle size to normal ldl in an individual, method for treating atherosclerotic diseases including vascular disease, coronary heart disease, cerebrovascular disease and peripheral vessel disease in an individual, method for treatment of inflammatory diseases, including rheumatoid arthritis, asthma, osteoarthritis and autoimmune disease in an individual, method of treating a disease or condition as measured by hppar-delta, method of modulating a peroxisome proliferator-activated receptor function ( ppar), and method of treating a disease or condition

摘要

COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF COMPOUND, METHOD FOR Raising HDL IN AN INDIVIDUAL, METHOD FOR TREATING TYPE 2 DIABETES, RESISTANCE TO REDUCED INSULIN OR REDUCTION OF SINDU INDIVIDUM IN BLOOD PRESSURE . METHOD FOR DISPLACING SMALL DENSIUM LDL PARTICULAR SIZE TO NORMAL LDL IN AN INDIVIDUAL, METHOD FOR TREATMENT OF AEROSCLEROTY DISEASES, VASCULAR CORONARY DISEASE, CORONARY VENTAL DISEASE, METHOD OF INFLAMMATORY DISEASES, INCLUDING RHEUMATIOUS ARTHRITIS, ASTHMA, OSTEODYCHROPHY AND AUTOIMMUNE DISEASE IN AN INDIVIDUAL, METHOD OF TREATMENT OF A DISEASE OR CONDITION MEASURED BY HPPAR-DELTA PERIPLATOR MODULATOR METHOD ), AND METHOD OF TREATING A DISEASE OR CONDITION These are aryl sulfonamide and sulfonyl compounds of formula (I) as peroxisome proliferator-activated receptor modulators, pharmaceutical compositions comprising the same and methods of treating disease which use them.